NCT06344793 Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT06344780 Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06344767 Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor Status COMPLETED Phase N/A
NCT06341842 Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity Status RECRUITING Phase PHASE2
NCT06341647 Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 Status WITHDRAWN Phase PHASE1
NCT06341621 Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib Status RECRUITING Phase PHASE3
NCT06341283 A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06340503 Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors Status ACTIVE_NOT_RECRUITING Phase NA
NCT06340386 Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC Status RECRUITING Phase N/A
NCT06340165 A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer Status RECRUITING Phase N/A
NCT06339658 ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy Status RECRUITING Phase N/A
NCT06337214 TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy Status RECRUITING Phase NA
NCT06336538 Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors Status ACTIVE_NOT_RECRUITING Phase NA
NCT06335069 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer. Status RECRUITING Phase PHASE2
NCT06334380 VR for Surgical Prehabilitation and Rehabilitation Status ENROLLING_BY_INVITATION Phase NA
NCT06332508 Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) Status COMPLETED Phase PHASE1